Karolinska University Hospital

Stockholm, Sweden

82 recruiting

Showing 120 of 179 trials

Recruiting
Phase 3

The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

Bronchiectasis
Boehringer Ingelheim1,755 enrolled470 locationsNCT06872892
Recruiting
Phase 3

EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

Kidney Disease, Chronic
Boehringer Ingelheim11,000 enrolled480 locationsNCT06531824
Recruiting
Phase 3

A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer

Endometrial Cancer
BioNTech SE480 enrolled171 locationsNCT06340568
Recruiting
Phase 3

A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)

Chronic Kidney Disease
Boehringer Ingelheim120 enrolled102 locationsNCT07107945
Recruiting

Alloplastic Total Temporomandibular Joint (TMJ) Replacement Registry

Temporomandibular Joint Disorders
AO Innovation Translation Center200 enrolled23 locationsNCT03991728
Recruiting

Prospective Natural History Study of POLG Disease

PolG, Primary Mitochondrial Myopathy
The POLG Foundation300 enrolledNCT07775872
Recruiting
Not Applicable

Prehospital Resuscitation Intranasal Cooling Effectiveness Survival Study 2

HypothermiaVentricular FibrillationOut-of-hospital cardiac arrest
Karolinska Institutet1,022 enrolled11 locationsNCT06025123
Recruiting

Molecular and Clinical Studies of Bone and Soft Tissue Tumors

Bone and Soft Tissue Tumors
Karolinska Institutet50,000 enrolledNCT07822204
Recruiting
Phase 3

Stereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer

Breast Cancer Stage IVOligometastatic Disease
Vastra Gotaland Region345 enrolled1 locationNCT05377047
Recruiting

Natural History of Type 1 Interferonopathies: Insights From a European Cohort

Genetic DiseaseAutoimmune DiseasesNeurological Diseases or Conditions+1 more
Imagine Institute500 enrolled32 locationsNCT07040774
Recruiting
Phase 3

A Clinical Study to Compare BupiZenge With Lidocaine for Pain Due to Oral Mucositis in Patients With Head and Neck Cancer.

Head & Neck CancerOral Mucositis
OncoZenge AB150 enrolled11 locationsNCT07672236
Recruiting
Phase 2

Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors

Medulloblastoma RecurrentEpendymoma RecurrentATRT Recurrent+1 more
Medical University of Vienna232 enrolled22 locationsNCT01356290
Recruiting
Phase 1Phase 2

Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

Carcinoma, Renal Cell
Oncorena AB75 enrolled5 locationsNCT05287945
Recruiting

Validation of Myocardial Perfusion and Extracellular Volume Assessment Using Photon-Counting Computed Tomography (PCCT) Compared With Cardiac Magnetic Resonance (CMR) in Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI)

Myocardial FibrosisStress PerfusionMyocardial Diseases+1 more
Karolinska University Hospital100 enrolledNCT07799363
Recruiting
Not Applicable

Photon Therapy Versus Proton Therapy in Early Tonsil Cancer.

Tonsil Cancer
Lund University Hospital100 enrolled12 locationsNCT03829033
Recruiting
Phase 3

Adjuvant Trial in Patients With Resected PDAC Randomized to Allocation of Oxaliplatin- or Gemcitabine-based Chemotherapy by Standard Clinical Criteria or by a Transcriptomic Treatment Specific Stratification Signature

Pancreatic Ductal Adenocarcinoma
John Neoptolemos394 enrolledNCT05314998
Recruiting
Phase 3

A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)

Chronic Hepatitis D Infection
Mirum Pharmaceuticals, Inc.172 enrolled48 locationsNCT07200908
Recruiting
Phase 3

A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs

Acromegaly
Debiopharm International SA119 enrolled72 locationsNCT06930625
Recruiting
Phase 3

A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

MyelofibrosisAnemia
Takeda324 enrolled207 locationsNCT07623161
Recruiting
Phase 3

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

Myelodysplastic Syndromes
Takeda225 enrolled179 locationsNCT06499285